BREAKING
Home » Archive by Category "Drugs and antibiotics" (Page 2)

FDA approves Ebanga for the treatment of Ebola

By

By News Desk  @bactiman63 Biotechnology company, Ridgeback Biotherapeutics, announced recently that the U.S. Food and Drug Administration (FDA) approved EbangaTM for the treatment of Ebola. Ebanga...

Vir Biotechnology & Gilead Announce Phase 2 Clinical Trial Collab for Functional Cure of Hepatitis B Virus

By

Gilead Sciences, Inc. and Vir Biotechnology, Inc. announced this week that the companies have entered into a clinical collaboration to evaluate novel therapeutic combination strategies aimed at developing...

Australia: GSK, MMV filing for Kozenis (tafenoquine) in pediatric populations accepted

By

GSK and Medicines for Malaria Venture (MMV) announced today that the Australian Therapeutic Goods Administration (TGA) accepted the submission of a Category 1 application to extend the indication of single-dose...

Eliminate sleeping sickness before 2030: Sanofi supports WHO in commitment

By

Sanofi has signed on December 10th a renewed partnership agreement with the World Health Organization (WHO), consolidating a 20-year collaboration to fight some of the most Neglected Tropical Diseases...

Mycobacterium abscessus: Johns Hopkins scientists develop a possible new antibiotic

By

Scientists from Johns Hopkins University and Medicine have developed a possible new antibiotic for a pathogen that is notoriously resistant to medications and frequently lethal for people with cystic fibrosis...

Vaginal Yeast Infections treatment, Oral Ibrexafungerp, receives FDA Acceptance and Priority Review of New Drug Application

By

SCYNEXIS, Inc., a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced that the U.S. Food and Drug Administration...

Influenza drug, Xofluza, receives expanded approval

By

By NewsDesk  @bactiman63 The U.S. Food and Drug Administration today expanded the approved indication for Xofluza (baloxavir marboxil) to include post-exposure prevention of influenza (flu) for patients...

Plasmodium vivax malaria: GSK and MMV present positive data on pediatric treatment

By

By NewsDesk  @bactiman63 GSK and Medicines for Malaria Venture (MMV) today presented positive data from the TEACH study of tafenoquine, an 8-aminoquinoline, for the prevention of relapse (radical cure)...

Chagas disease: Research shows stronger but less frequent drug doses could be key to cure

By

By NewsDesk  @bactiman63 Researchers in the University of Georgia’s Center for Tropical and Emerging Global Diseases have found that a more intensive, less frequent drug regimen with currently...

Head Lice: FDA approves Sklice lotion to OTC use

By

Today, the U.S. Food and Drug Administration approved a lotion to treat head lice for nonprescription, or over-the-counter (OTC), use through a process called a prescription (Rx)-to-OTC switch. The FDA...